|
|
Volumn 54, Issue 6, 1997, Pages 626-
|
|
Aggressive lipid-lowering therapy beneficial after bypass grafting, say researchers.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTICOAGULANT AGENT;
ANTILIPEMIC AGENT;
COLESTYRAMINE;
HYPOCHOLESTEROLEMIC AGENT;
MEVINOLIN;
WARFARIN;
ARTICLE;
CLINICAL TRIAL;
CORONARY ARTERY BYPASS GRAFT;
GRAFT OCCLUSION;
HUMAN;
ANTICHOLESTEREMIC AGENTS;
ANTICOAGULANTS;
ANTILIPEMIC AGENTS;
CHOLESTYRAMINE;
CLINICAL TRIALS;
CORONARY ARTERY BYPASS;
GRAFT OCCLUSION, VASCULAR;
HUMANS;
LOVASTATIN;
WARFARIN;
|
|
EID: 0031569202
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/54.6.626a Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|